These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 8161744)

  • 1. [The value of the liver-specific superparamagnetic contrast medium AMI-25 for the detection and differential diagnosis of primary liver tumors versus metastases].
    Vogl TJ; Hammerstingl R; Pegios W; Hamm B; Eibl-Eibesfeldt A; Woessmer B; Lissner J; Felix R
    Rofo; 1994 Apr; 160(4):319-28. PubMed ID: 8161744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem].
    Vogl TJ; Hammerstingl R; Keck H; Felix R
    Radiologe; 1995 Nov; 35(11 Suppl 2):S258-66. PubMed ID: 8588032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dynamic and static MRI using superparamagnetic MRI contrast medium Resovist for visualizing primary and secondary liver tumors].
    Vogl TJ; Schwarz W; Hammerstingl R; Kümmel S; Balzer JO; Mack MG; Diebold T; Balzer T; Shamsi K; Bechstein WO; Schrem H; Neuhaus P; Felix R
    Rofo; 1997 Sep; 167(3):264-73. PubMed ID: 9376555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Superparamagnetic iron particles. The clinical results in the MR diagnosis of liver metastases].
    Ham B; Reichel M; Vogl T; Taupitz M; Wolf KJ
    Rofo; 1994 Jan; 160(1):52-8. PubMed ID: 8305693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of focal hepatic lesions: effects of superparamagnetic iron oxide (AMI-25) on magnetic resonance imaging of the liver using T2-weighted fast spin-echo sequences and gradient-and-spin-echo sequences at 1.0 tesla.
    Jung G; Krahe T; Kugel H; Gieseke J; Walter C; Lackner K
    Invest Radiol; 1998 Feb; 33(2):61-7. PubMed ID: 9493719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The MR tomography of focal liver lesions with the superparamagnetic contrast agent AMI-25 at 1.5 tesla].
    Duda SH; Laniado M; Kopp AF; Grönewäller E; Aicher KP; Pavone P; Jehle E; Claussen CD
    Rofo; 1994 Jan; 160(1):46-51. PubMed ID: 8305692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227).
    Saini S; Edelman RR; Sharma P; Li W; Mayo-Smith W; Slater GJ; Eisenberg PJ; Hahn PF
    AJR Am J Roentgenol; 1995 May; 164(5):1147-52. PubMed ID: 7717222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New super-paramagnetic iron particles for MRI. Phase II study of malignant liver tumors].
    Daldrup HE; Reimer P; Rummeny EJ; Tombach B; Berns T; Balzer T; Schimpfky C; Peters PE
    Radiologe; 1995 Aug; 35(8):486-93. PubMed ID: 7568792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Superparamagnetic iron oxide in the differential diagnosis of focal hepatic lesions using a 0.5-tesla magnetic resonance apparatus].
    Di Cesare E; Cariello G; Marchese F; Michelini O; Costanzi A; Catalucci A; Splendiani A; Masciocchi C
    Radiol Med; 1998 Jun; 95(6):593-8. PubMed ID: 9717541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Focal liver lesions. A comparison between magnetic resonance under base conditions and after a superparamagentic contrast medium].
    Finazzo M; Midiri M; Gallo C; Bartolotta TV; Luca A
    Radiol Med; 1998 Jun; 95(6):599-607. PubMed ID: 9717542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging.
    Yamamoto H; Yamashita Y; Yoshimatsu S; Baba Y; Hatanaka Y; Murakami R; Nishiharu T; Takahashi M; Higashida Y; Moribe N
    Radiology; 1995 Apr; 195(1):106-12. PubMed ID: 7892448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of superparamagnetic iron oxide (AMI-25) on liver and spleen imaging using spin-echo and fast spin-echo magnetic resonance pulse sequences.
    Schwartz LH; Seltzer SE; Adams DF; Tempany CM; Piwnica-Worms DR; Silverman SG; Herman L; Herman LT; Hooshmand R
    Invest Radiol; 1994 Jun; 29 Suppl 2():S21-3. PubMed ID: 7928234
    [No Abstract]   [Full Text] [Related]  

  • 13. Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging.
    Bellin MF; Zaim S; Auberton E; Sarfati G; Duron JJ; Khayat D; Grellet J
    Radiology; 1994 Dec; 193(3):657-63. PubMed ID: 7972804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical application of AMI-25 (superparamagnetic iron oxide) for the MR imaging of hepatic tumors: a multicenter clinical phase III study].
    Yoshikawa K; Sasaki Y; Ogawa N; Sakuma S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Feb; 54(2):137-53. PubMed ID: 8121779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions.
    Winter TC; Freeny PC; Nghiem HV; Mack LA; Patten RM; Thomas CR; Elliott S
    AJR Am J Roentgenol; 1993 Dec; 161(6):1191-8. PubMed ID: 8249724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical results with Resovist: a phase 2 clinical trial.
    Reimer P; Rummeny EJ; Daldrup HE; Balzer T; Tombach B; Berns T; Peters PE
    Radiology; 1995 May; 195(2):489-96. PubMed ID: 7724772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent.
    Maccioni F; Bruni A; Viscido A; Colaiacomo MC; Cocco A; Montesani C; Caprilli R; Marini M
    Radiology; 2006 Feb; 238(2):517-30. PubMed ID: 16371574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration.
    Grandin C; Van Beers BE; Robert A; Gigot JF; Geubel A; Pringot J
    J Comput Assist Tomogr; 1995; 19(3):412-8. PubMed ID: 7790551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superparamagnetic iron oxide-enhanced magnetic resonance imaging of experimental liver tumors after mitomycin C administration.
    Clement O; Frija G; Chambon C; Schouman-Clayes E
    Invest Radiol; 1992 Mar; 27(3):230-5. PubMed ID: 1551774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with Resovist in gastroenterologic radiology and intervention.
    Vogl TJ; Schwarz W; Marquart F; Parmentier S; Götz B; Thalhammer A; Hammerstingl R
    Eur Radiol; 2004 Jan; 14 Suppl 1():C7-9. PubMed ID: 15113060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.